We have identified cis-acting elements and trans-acting factors that regulate constitutive expression of the human antithrombin gene. The activity of the sequences flanking the first exon of the gene was investigated using a luciferase-based reporter assay in transiently transfected HepG2, COS1, BSC40, and HeLa cells. Deletion analysis allowed the mapping of two elements able to promote antithrombin gene transcription in HepG2 and COS1 cells. The first element is located upstream of the first exon (؊150/؉68 nucleotides). The second element is in the first intervening sequence (؉300/؉700 nucleotides) and functions in an orientation opposite to that of the first. Footprint analysis showed three protected areas in the 5 upstream element at ؊92/؊68 (element A), ؊14/؉37 (element B), and ؊126/؊100 nucleotides (element C). These elements acted as enhancers in luciferase reporter assays. Gel retardation analysis demonstrated that two liver-enriched transcription factors, hepatocyte nuclear factor 4 (HNF4) and CCAAT enhancer-binding protein (C/EBPa), bound to the 5 upstream element. HNF4 bound to elements A and C, whereas C/EBPa bound to element B. Element A also interacted with the ubiquitous nuclear hormone receptors chicken ovalbumin upstream promoter transcription factor 1 (COUP-TF1), thyroid hormone receptor ␣ (TR␣), peroxisome proliferator-activated receptor ␣(PPAR␣), and retinoid X receptor ␣ (RXR␣). In HepG2 and BSC40 cells, HNF4, C/EBP␣, and RXR␣ activated luciferase expression from a reporter construct containing the 5-upstream minimal antithrombin gene promoter, while COUP-TF1, TR␣, and HNF3 (␣ or ) repressed such expression. Our results show that constitutive expression of the human antithrombin gene depends in part upon the interplay of these transcription factors and suggest that signaling pathways regulated by these factors can modulate antithrombin gene transcription.
Human antithrombin (AT)1 is a major inhibitor of a number of serine esterases implicated in blood coagulation (1, 2). The AT gene contains 7 exons and 6 intervening sequences (IVS) in a 14-kilobase pair region of the long arm of chromosome 1. The mechanisms underlying AT gene expression are not well known. The AT gene is expressed primarily in the liver, with lower levels in the kidney and brain (2). AT gene expression is believed to be constitutive, but developmental and hormonal factors are known to influence AT levels in plasma (2). At the transcriptional level, an early report by Prochownik described enhancer activity of a Ϫ340/ϩ1200 nucleotide (nt) fragment of the AT gene (3), while Ochoa et al. (4), investigating the regulation of expression of the human transferrin gene, identified a sequence at Ϫ480/Ϫ458 nt that contained the core motif TCT-TTGACCT. This element, named TF-DRI, was shown to be homologous with an element at Ϫ89/Ϫ75 nt in the human AT gene, and generated shifts in liver nuclear extracts in a tissuespecific manner (4). These observations prompted us to characterize in greater detail elements in this area of the human AT...